Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | CES2 | O00748 | 2/20 | 0.50 |
| ▸ | CES1 | P23141 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27389912 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| SCHEMBL567396 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| SCHEMBL11767588 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| SCHEMBL28645326 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| SCHEMBL6462426 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| SCHEMBL825240 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| SCHEMBL29105916 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| SCHEMBL8756235 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| SCHEMBL6130417 | 1.00 | LMNA (0.54) | LMNATSHRALDH1A1TDP1F2 | |
| Bicarbonate SCHEMBL28738435 | 0.98 | LMNA (0.53) | LMNATSHRALDH1A1TDP1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117050034-A | Multifunctional benzothiadiazole Schiff base luminescent liquid crystal and preparation and application thereof | 云南大学 | 2023-11-14 | — | — | CN | claimed |
| CN-117586249-A | D-A-D type luminous liquid crystal based on benzothiadiazole and preparation and application thereof | 云南大学 | 2024-02-23 | — | — | CN | disclosed |
| CN-117050034-A | Multifunctional benzothiadiazole Schiff base luminescent liquid crystal and preparation and application thereof | 云南大学 | 2023-11-14 | — | — | CN | disclosed |
| CN-109485582-B | Fluorenone-based organogel molecule and preparation method and application thereof | 南京工业大学 | 2020-07-17 | — | — | CN | disclosed |
| EP-2061524-A2 | COLOR CHANGING SKIN SEALANT | Kimberly-Clark Worldwide, Inc. (US) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008032231-A2 | COLOR CHANGING SKIN SEALANT | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2008-03-20 | — | — | WO | disclosed |
| US-20080063615-A1 | Color changing skin sealant | KIMBERLY-CLARK WORLDWIDE, INC. | 2008-03-13 | — | — | US | disclosed |
| EP-1159014-B1 | ARTICLES COMPRISING OXIDISING AND HEMOLYTIC AGENTS | PROCTER & GAMBLE (US) | 2007-04-18 | — | — | EP | disclosed |
| US-6730819-B1 | PEROXYACID; SANITARY NAPKINS; DISPOSABLE PRODUCTS | THE PROCTER & GAMBLE COMPANY | 2004-05-04 | — | — | US | disclosed |
| EP-1159014-A1 | ARTICLES COMPRISING OXIDISING AND HEMOLYTIC AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 2001-12-05 | — | — | EP | disclosed |
| EP-1034803-A1 | Breathable absorbent articles having an oxidising agent based odour control system | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-1034800-A1 | Articles having an odour control system comprising an oxidising agent and an odour absorbing agent | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-1034804-A1 | Articles comprising an oxidising agent and a hemolytic agent | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-1034805-A1 | Articles having an odour control system comprising a non water soluble oxidising agent and a solubilising agent | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-1034801-A1 | Absorbent articles having an odour control system comprising an oxidising agent and a chelating agent | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-13 | — | — | EP | disclosed |
| WO-2000051652-A1 | ARTICLES HAVING AN ODOUR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051651-A1 | ABSORBENT ARTICLES HAVING AN ODOUR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051654-A1 | ARTICLES HAVING AN ODOUR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051656-A1 | BREATHABLE ABSORBENT ARTICLES HAVING AN OXIDISING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051655-A1 | ARTICLES COMPRISING OXIDISING AND HEMOLYTIC AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080063615-A1 | Color changing skin sealant | CUTA, PROC, RBP1 | LMNA 293/4885TSHR 3126/4885ALDH1A1 855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.